Your browser doesn't support javascript.
loading
Access to innovative medicines for metastatic melanoma worldwide: Melanoma World Society and European Association of Dermato-oncology survey in 34 countries.
Kandolf Sekulovic, L; Guo, J; Agarwala, S; Hauschild, A; McArthur, G; Cinat, G; Wainstein, A; Caglevic, C; Lorigan, P; Gogas, H; Alvarez, M; Duncombe, R; Lebbe, C; Peris, K; Rutkowski, P; Stratigos, A; Forsea, A-M; De La Cruz Merino, L; Kukushkina, M; Dummer, R; Hoeller, C; Gorry, C; Bastholt, L; Herceg, D; Neyns, B; Vieira, R; Arenberger, P; Bylaite-Bucinskiene, M; Babovic, N; Banjin, M; Putnik, K; Todorovic, V; Kirov, K; Ocvirk, J; Zhukavets, A; Ymeri, A; Stojkovski, I; Garbe, C.
Afiliação
  • Kandolf Sekulovic L; Department of Dermatology, Faculty of Medicine, Military Medical Academy, Belgrade, Serbia. Electronic address: lkandolfsekulovic@gmail.com.
  • Guo J; Department of Urology and Melanoma, Peking University Cancer Hospital & Institute, Beijing, PR China.
  • Agarwala S; St. Luke's University Hospital and Temple University, Bethlehem, USA.
  • Hauschild A; Department of Dermatology, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, Kiel, Germany.
  • McArthur G; Divisions of Research and Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, VIC, 3000, Australia.
  • Cinat G; Médica Oncóloga Instituto de Oncología Angel Roffo, Universidad de Buenos Aires Fundación CIDEA, Buenos Aires, Argentina.
  • Wainstein A; Institute of Post-graduation, Faculdade de Ciências Médicas de Minas Gerais (FCM-MG) - Belo Horizonte (MG), Brazil.
  • Caglevic C; Medical Oncology Service, Oncology Department, Clinica Alemana Santiago, Faculty of Medicine Clinica Alemana-Universidad Del Desarrollo, Santiago, Chile.
  • Lorigan P; Institute of Cancer Sciences, University of Manchester, The Christie NHS Foundation Trust, Manchester, UK.
  • Gogas H; 1(st)Department of Internal Medicine, Laiko Hospital and 1st Department of Dermatology-Venereology, Andreas Sygros Hospital, National and Kapodistrian University of Athens, Athens, Greece.
  • Alvarez M; Medico en Instituto Nacional de Cancerologia, Mexico City Area, Mexico.
  • Duncombe R; Institute of Cancer Sciences, University of Manchester, The Christie NHS Foundation Trust, Manchester, UK.
  • Lebbe C; APHP Dermatology Department, University Paris 7 Diderot, INSERM U976, PARIS, France.
  • Peris K; Institute of Dermatology, Catholic University of the Sacred Heart, Rome, Italy.
  • Rutkowski P; Maria Sklodowska-Curie Institute - Oncology Center, Warsaw, Poland.
  • Stratigos A; 1(st)Department of Internal Medicine, Laiko Hospital and 1st Department of Dermatology-Venereology, Andreas Sygros Hospital, National and Kapodistrian University of Athens, Athens, Greece.
  • Forsea AM; Carol Davila University of Medicine and Pharmacy, Elias University Hospital Bucharest, Romania.
  • De La Cruz Merino L; Department of Clinical Oncology, Hospital Universitario Virgen Macarena, Sevilla, Spain.
  • Kukushkina M; National Cancer Institute, Kiev, Ukraine.
  • Dummer R; UniversitätsSpital Zürich-Skin Cancer Center, University Hospital, Zürich, Switzerland.
  • Hoeller C; Department of Dermatology, Medical University of Vienna, Vienna, Austria.
  • Gorry C; National Centre for Pharmacoeconomics, Old Stone Building, Trinity Centre for Health Sciences, St. James's Hospital, Dublin 8, Ireland.
  • Bastholt L; Department of Oncology, Odense University Hospital, Denmark.
  • Herceg D; Department of Oncology, University Hospital Zagreb, Croatia.
  • Neyns B; Department of Medical Oncology, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel (VUB), Brussels, Belgium.
  • Vieira R; Department of Dermatology, Medical Faculty, University of Coimbra, Portugal.
  • Arenberger P; Department of Dermatovenereology, Charles University 3rd Faculty of Medicine and University Hospital Kralovske Vinohrady, Prague, Czech Republic.
  • Bylaite-Bucinskiene M; Department of Dermatology, Vilnius University, Lithuania.
  • Babovic N; Institute of Oncology and Radiology of Serbia, Belgrade, Serbia.
  • Banjin M; Department of Oncology, University Hospital Sarajevo, Bosnia and Herzegovina.
  • Putnik K; North Estonia Medical Centre, Tallinn, Estonia.
  • Todorovic V; Clinic for Oncology and Radiotherapy, Podgorica, Montenegro.
  • Kirov K; Clinic of Oncodermatology, National Cancer Center, Sofia, Bulgaria.
  • Ocvirk J; Institute of Oncology Ljubljana, Ljubljana, Slovenia.
  • Zhukavets A; Belarusian Medical Academy of Postgraduate Education (BelMAPE), Minsk, Belarus.
  • Ymeri A; University Hospital Mother Theresa, Tirana, Albania.
  • Stojkovski I; University Clinic of Radiotherapy and Oncology, Skopje, Macedonia.
  • Garbe C; Centre for Dermatooncology, Department of Dermatology, Eberhard Karls University, Tuebingen, Germany.
Eur J Cancer ; 104: 201-209, 2018 11.
Article em En | MEDLINE | ID: mdl-30388700
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Drogas em Investigação / Melanoma Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Drogas em Investigação / Melanoma Idioma: En Ano de publicação: 2018 Tipo de documento: Article